News - BioPharm International

ADVERTISEMENT

News

J&J Speeds Ebola Vaccine Development and Expands Production

October 24, 2014

Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an ebola vaccine.

Manufacturing Challenges of mAb Production: CHO or Plant Cells?

October 24, 2014

The latest Ebola epidemic sheds light on the delicate processes surrounding the manufacture of genetically modified live cells for biopharmaceutical production.

GSK Accelerates Ebola Vaccine Development

October 24, 2014

GSK's investigational Ebola vaccine is in Phase I safety trials.

Celgene and Sutro Partner on ADC Development

October 24, 2014

Celgene expands its oncology drug discovery and development portfolio through a new partnership with Sutro.

Unum Raises $12 million in Funding for ACTR-Based Cancer Treatment

October 24, 2014

Unum Therapeutics raised $12 million in Series A funding for its development of antibody-coupled T cell receptors (ACTRs) for the treatment of nonspecific tumor cells.

Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials

October 23, 2014

Secukinumab is the first IL-17A inhibitor to meet its primary endpoint in two Phase III trials for patients with ankylosing spondylitis.

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis

October 22, 2014

An advisory committee recommends use of the first psoriasis therapy targeting IL-17A.

Pall ForteBio Releases Bioprocessing Contamination Detection Kit

October 22, 2014

Pall ForteBio introduces a solution for quantifying residual host cell proteins in CHO cells.

Roche to Expand and Improve its Basel Site

October 22, 2014

The renovation to Roche's historic office building in Basel, Switzerland will feature sustainable workplaces and a state-of-the-art research center.

ADVERTISEMENT

ADVERTISEMENT

Click here